We provide 1 form of Abemaciclib
Abemaciclib
1231929-97-7
|
506.272
|
4.915
Abemaciclib is an antitumor agent and dual inhibitor of cyclin-dependent kinases 4 and 6 that are involved in the cell cycle and promotion of cancer cell growth in case of unregulated activity. Abemaciclib is used to treat HR+ HER2- advanced or metastatic breast cancer.
LY2835219 | abemacicilib | abemaciclib | bemaciclib | verzenio
Abemaciclib is an antitumor agent and dual inhibitor of cyclin-dependent kinases 4 and 6 that are involved in the cell cycle and promotion of cancer cell growth in case of unregulated activity. Abemaciclib is used to treat HR+ HER2- advanced or metastatic breast cancer.
LY2835219 | abemacicilib | abemaciclib | bemaciclib | verzenio
$67/5 mg
(EBC)
1
We provide 0 compound for Abemaciclib